Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gniadecki

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
The British Journal of Dermatology|November 3, 2017
Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasisA Egeberg, M B Ottosen, R Gniadecki, et al.
Journal of Internal Medicine|September 12, 2012
Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort studyO Ahlehoff, L Skov, G Gislason, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 11, 2014
Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohortO Ahlehoff, L Skov, G Gislason, et al.
The British Journal of Dermatology|October 15, 2013
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomesM Augustin, C Blome, A Costanzo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 5, 2015
Patient-relevant needs and treatment goals in nail psoriasisC Blome, A Costanzo, E Dauden, et al.
Frontiers in Medicine|December 5, 2025
Editorial: Pioneers & pathfinders: 10 years of frontiers in medicineM Goldman, A Chen, J Bloomfield, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2021
Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyondJ Beecker, K A Papp, J Dutz, et al.
Leukemia|September 5, 2008
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndromeT Krejsgaard, L M Gjerdrum, E Ralfkiaer, et al.
The Pharmacogenomics Journal|July 12, 2017
Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasisN D Loft, L Skov, L Iversen, et al.
Experimental Dermatology|September 21, 2006
Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"?M Amagai, A R Ahmed, Y Kitajima, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
The British Journal of Dermatology|November 3, 2017
Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasisA Egeberg, M B Ottosen, R Gniadecki, et al.
Journal of Internal Medicine|September 12, 2012
Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort studyO Ahlehoff, L Skov, G Gislason, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 11, 2014
Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohortO Ahlehoff, L Skov, G Gislason, et al.
The British Journal of Dermatology|October 15, 2013
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomesM Augustin, C Blome, A Costanzo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 5, 2015
Patient-relevant needs and treatment goals in nail psoriasisC Blome, A Costanzo, E Dauden, et al.
Frontiers in Medicine|December 5, 2025
Editorial: Pioneers & pathfinders: 10 years of frontiers in medicineM Goldman, A Chen, J Bloomfield, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2021
Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyondJ Beecker, K A Papp, J Dutz, et al.
Leukemia|September 5, 2008
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndromeT Krejsgaard, L M Gjerdrum, E Ralfkiaer, et al.
The Pharmacogenomics Journal|July 12, 2017
Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasisN D Loft, L Skov, L Iversen, et al.
Experimental Dermatology|September 21, 2006
Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"?M Amagai, A R Ahmed, Y Kitajima, et al.
Pageof 10